Competitive: Barrington James: Medical Lead - Neurology SUMMARY: The Medical Lead, Clinical Development will assume a pivotal role in shaping the...
Vous n'êtes pas connecté
GREENVILLE, S.C. — Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A. Ibara, Pharm.D., as Chief Strategy Officer (CSO). Dr. Ibara will lead the company’s global strategic initiatives to transform the clinical trial sector with leading-edge technology solutions. Dr. Ibara will lead the launch of Avallano’s generative AI technologies, aimed at […]
Competitive: Barrington James: Medical Lead - Neurology SUMMARY: The Medical Lead, Clinical Development will assume a pivotal role in shaping the...
Sergey serves as Chief Technology Officer at IntelePeer, responsible for developing technology strategy plans aligning with IntelePeer’s long-term...
Pharos Energy, an independent energy company, has announced the appointment of Katherine Roe as the Company's new Chief Executive Officer (CEO) with...
Generative AI (GenAI)-enabled software development will improve productivity and work efficiency – the question is, how much? Most market research...
Last year, Mastercard chief marketing and communications officer Raja Rajamannar invited the company's chief financial officer, Sachin Mehra, to...
Australian cyber security business CSO Group will merge with automation systems and artificial intelligence integrator xAmplify. Once complete, the...
Bermudian-based Phil Schmidt has been appointed chief strategy officer of Markel, the insurance operations within Markel Group Inc. The company said...
SIRI SYSTEMATIC STRATEGY proudly announces that SUKHVINDER S SIDHU, Chief Strategy Analyst, and VINEET GUPTA, Chief Trading Officer, attended the AI...